February 15, 2024 06:00 AM ESTUpdated 06:23 AM
Financing
Diagnostics

Freenome rais­es $254M for ear­ly can­cer de­tec­tion tests

Jared Whitlock

Features Editor

Freenome has raised an ad­di­tion­al $254 mil­lion in pri­vate fund­ing, led by Roche, as the com­pa­ny nears piv­otal re­sults for its blood-based can­cer test. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times